These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 6009820)

  • 21. Recent advances in paclitaxel-containing chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck.
    Shin DM; Glisson BS; Khuri FR; Ginsberg L; Lawhorn K; Hong WK; Lippman SM
    Semin Oncol; 1997 Dec; 24(6 Suppl 19):S19-33-S19-37. PubMed ID: 9427263
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aggressive simultaneous radiochemotherapy with cisplatin and paclitaxel in combination with accelerated hyperfractionated radiotherapy in locally advanced head and neck tumors. Results of a phase I-II trial.
    Kuhnt T; Becker A; Pigorsch S; Pelz T; Bloching M; Passmann M; Lotterer E; Hänsgen G; Dunst J
    Strahlenther Onkol; 2003 Oct; 179(10):673-81. PubMed ID: 14566475
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The present situation of neoadjuvant therapy for head and neck carcinoma].
    Rikimaru F; Tomita K
    Gan To Kagaku Ryoho; 2007 Oct; 34(10):1535-7. PubMed ID: 17940367
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hypothermia with epodyl in the treatment of cancer of the head and neck.
    Harrison DF
    Geriatrics; 1969 Jul; 24(7):87-97. PubMed ID: 5789862
    [No Abstract]   [Full Text] [Related]  

  • 25. Limitations in intra-arterial infusions of chemotherapy for head and neck cancer.
    Yoshizaki T
    Gan To Kagaku Ryoho; 2008 Jul; 35(7):1106-9. PubMed ID: 18686358
    [No Abstract]   [Full Text] [Related]  

  • 26. [The effect of the microenvironment of head and neck cancers on tumor progression].
    Lukits J
    Magy Onkol; 2009 Mar; 53(1):51-9. PubMed ID: 19318327
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypothermia: an aid to cancer chemotherapy.
    Harrison DF
    Nurs Times; 1967 Nov; 63(46):1536-8. PubMed ID: 6054792
    [No Abstract]   [Full Text] [Related]  

  • 28. Relative contributions of radiation and cisplatin-based chemotherapy to sensorineural hearing loss in head-and-neck cancer patients.
    Hitchcock YJ; Tward JD; Szabo A; Bentz BG; Shrieve DC
    Int J Radiat Oncol Biol Phys; 2009 Mar; 73(3):779-88. PubMed ID: 18707819
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cisplatin: impact of a new anticancer agent on current therapeutic strategies.
    Rozencweig M; Abele R; von Hoff DD; Muggia FM
    Anticancer Res; 1981; 1(4):199-204. PubMed ID: 7049048
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A phase I/II study of paclitaxel plus cisplatin as first-line therapy for head and neck cancers: preliminary results.
    Hitt R; Hornedo J; Colomer R; Mendiola C; Brandariz A; Sevilla E; Alvarez-Vicent J; Cortés-Funes H
    Semin Oncol; 1995 Dec; 22(6 Suppl 15):50-4. PubMed ID: 8643971
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Decreased hearing after combined modality therapy for head and neck cancer.
    Pearson SE; Meyer AC; Adams GL; Ondrey FG
    Am J Otolaryngol; 2006; 27(2):76-80. PubMed ID: 16500467
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chemotherapy of head and neck cancer.
    Wittes RE
    Otolaryngol Clin North Am; 1980; 13(3):515-20. PubMed ID: 7003480
    [No Abstract]   [Full Text] [Related]  

  • 33. [Chemotherapy of malignant tumors by arterial approach].
    Escó Barón R
    Rev Med Univ Navarra; 1983 Mar; 27(1):9-20. PubMed ID: 6669836
    [No Abstract]   [Full Text] [Related]  

  • 34. Intra-arterial chemotherapy for head and neck cancer: is there a verdict?
    Rasch CR; Hauptmann M; Balm AJ
    Cancer; 2011 Feb; 117(4):874; author reply; 874-5. PubMed ID: 20922790
    [No Abstract]   [Full Text] [Related]  

  • 35. Head and neck carcinoma with distant metastases: a retrospective analysis of 44 cases treated with cisplatin-based chemotherapeutic regimens.
    Gebbia V; Agostara B; Callari A; Zerillo G; Restivo G; Speciale R; Cupido G; Ingria F; Spatafora G; Fazio L
    Anticancer Res; 1993; 13(4):1129-31. PubMed ID: 8352535
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phase II study of rubitecan in recurrent or metastatic head and neck cancer.
    Caponigro F; Cartenì G; Droz JP; Milano A; Davis WB; Pollard P
    Cancer Chemother Pharmacol; 2008 Jul; 62(2):209-14. PubMed ID: 17882418
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prediction of distant metastasis in head neck cancer patients: implications for induction chemotherapy and pre-treatment staging?
    Studer G; Seifert B; Glanzmann C
    Strahlenther Onkol; 2008 Nov; 184(11):580-5. PubMed ID: 19016016
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Intra-arterial chemotherapy in the treatment of cancers of the head and neck].
    Restrepo Angel F; Gómez J; Bernal P
    Rev Fac Med Univ Nac Colomb; 1965; 33(3):71-7. PubMed ID: 5880912
    [No Abstract]   [Full Text] [Related]  

  • 39. Chemotherapy in the treatment of head and neck cancer.
    Daly JF
    Minn Med; 1967 Jun; 50(6):1016-9. PubMed ID: 6041495
    [No Abstract]   [Full Text] [Related]  

  • 40. Chemoradiation therapy using radiotherapy, systemic chemotherapy with 5-fluorouracil and nedaplatin, and intra-arterial infusion using carboplatin for locally advanced head and neck cancer - Phase II study.
    Fuwa N; Kodaira T; Furutani K; Tachibana H; Nakamura T; Daimon T
    Oral Oncol; 2007 Nov; 43(10):1014-20. PubMed ID: 17258494
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.